Filter
4870
Filtered Results: 4870
Text search:
Drug
research
Featured
Recommendations
398
New Publications
1275
Language
Document type
No document type
3028
Studies & Reports
791
Guidelines
556
Manuals
178
Strategic & Response Plan
141
Fact sheets
70
Training Material
50
Situation Updates
19
Infographics
13
Brochures
10
Resource Platforms
9
Online Courses
3
App
1
Videos
1
Countries / Regions
India
272
Global
156
Kenya
154
Western and Central Europe
111
Ethiopia
110
Uganda
108
South Africa
106
Nigeria
103
Nepal
90
Malawi
79
Liberia
79
Africa
78
Zambia
76
Sierra Leone
73
Tanzania
73
Latin America and the Carribbean
66
Myanmar / Burma
66
Ghana
65
Bangladesh
61
Ukraine
57
Eastern Europe
56
Rwanda
52
Philippines
43
Russia
43
Asia
40
Zimbabwe
39
Namibia
37
Cambodia
36
South–East Asia Region
33
Lesotho
32
Indonesia
30
Mozambique
24
Congo, Democratic Republic of
23
Brazil
23
Botswana
22
Senegal
21
Syria
20
Germany
18
East and Southern Africa
18
Burkina Faso
17
Eswatini/ Swaziland
17
Colombia
16
West and Central Africa
16
South Sudan
16
Tajikistan
15
Middle East and North Africa
15
USA
14
Cameroon
13
Haiti
12
Thailand
11
Albania
11
Eastern Europe and Central Asia
11
Pakistan
11
Argentina
10
Sudan
10
Georgia
10
China
9
Guinea
9
Vietnam
9
Afghanistan
8
Venezuela
8
North Macedonia
7
Laos
7
Armenia
7
Moldova
7
Benin
6
Mexico
5
Peru
5
Western Pacific Region
5
Sri Lanka
5
Yemen
5
Iraq
5
Jordan
4
United Kingdom
4
Southern Africa
4
Lebanon
4
Central African Republic
4
Angola
4
Timor Leste/ East Timor
3
Serbia
3
Turkey
3
Chile
3
Iran
3
Kyrgyzstan
3
Guinea-Bissau
3
Paraguay
3
Jamaica
3
Belarus
3
Papua New Guinea
3
Libya
3
Bhutan
3
Somalia
3
El Salvador
2
Kazakhstan
2
Canada
2
Estonia
2
Morocco
2
Hungary
2
Saudi Arabia
2
North America
2
Belgium
2
Portugal
2
Palestine
2
Poland
2
Mali
2
Ecuador
2
North Korea
1
Australia
1
Gambia
1
Fiji
1
Singapore
1
Uzbekistan
1
Mongolia
1
Qatar
1
Italy
1
Ireland
1
Gabon
1
Turkmenistan
1
Denmark
1
France
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Spain
1
Côte d’Ivoire / Ivory Coast
1
Bolivia
1
Egypt
1
Romania
1
Greece
1
Honduras
1
Chad
1
Authors & Publishers
Publication Years
Category
Countries
1805
Clinical Guidelines
435
Public Health
246
Women & Child Health
182
Key Resources
85
Pharmacy & Technologies
64
Capacity Building
59
Annual Report MEDBOX
1
Toolboxes
HIV
578
Mental Health
565
TB
497
AMR
267
COVID-19
211
NTDs
180
Pharmacy
126
NCDs
103
Caregiver
81
Ebola
78
Planetary Health
76
Rapid Response
73
Disability
56
Refugee
54
Global Health Education
53
Conflict
45
Health Financing Toolbox
30
Polio
19
Natural Hazards
16
Specific Hazards
15
Zika
15
Social Ethics
12
Cholera
10
Health Financing
1
This study addresses part of the Terms of Reference for a scoping report ‘An analysis of approaches to laboratory capacity strengthening for drug resistant infections in low and middle income countries’. It has been produced as a separate report because it is also very relevant for a second stud...
Stenotrophomonas maltophiliais a nonfermenting Gram-negative rod that is ubiquitous in nature (predominantly occurring in aquatic environments and on plants). Biochemically, it iscatalase positive and oxidase negative, and it produces acid frommaltose (hence the name“maltophilia”). Due to it...
Antimicrobial resistance is one of the most important threats to the health worldwide. Antimicrobial resistance or drug resistance is the reduction of the pharmaceutical effects of a drug against a disease or reduction of its effectiveness in improving the clinical signs of a disease. Antimicrobial ...
The consolidated guidelines are complemented by an operational handbook which is designed to assist with implementation of the WHO recommendations by Member States, technical partners and others who are involved in the management of patients with DR-TB. The WHO Operational Handbook on Tuberculosis, ...
During the first two years of the project (2019–2020), through a ‘One Health’ approach, comprehensive engagement was established with AMR coordinating committees, WHO regional and country offices and SORT IT partners in Asia, Africa, Europe and the Americas. Thirty-seven research studies were ...
Yaws is targeted for eradication by 2030, using a strategy based on mass drug administration (MDA) with azithromycin. New diagnostics are needed to aid eradication. Serology is currently the mainstay for yaws diagnosis; however, inaccuracies associated with current serological tests makes it difficu...
Review over the work and challenges of the Nigerian National Agency for Food and Drug Administration and Control (NAFDAC) in combatting counterfeiting of medicines in Nigeria.
This guide is a resource for physicians and other health care professionals who provide care and treatment to patients with drug-resistant tuberculosis.
Community Health Workers in Sub Saharan Africa
recommended
A booklet on how CHWs were addressing eye health across Africa based on desk research and a survey in 23 countries
Commissioned by Plan International the report draws on data from research conducted in Bangladesh in April 2018. It explores how adolescent girls within two age brackets (10-14 and 15-19) understand the unique impact the crisis has upon them, and how they have responded to the challenges they face.<...
WHO operational handbook on tuberculosis: module 4: treatment: tuberculosis care and support
recommended
The consolidated guidelines are complemented by an operational handbook which is designed to assist with implementation of the WHO recommendations by Member States, technical partners and others who are involved in the management of patients with DR-TB. The WHO Operational Handbook on Tuberculosis, ...
Accessed on 31.03.2023
COUNTDOWN Nigeria has applied a Participatory Action Research (PAR) approach to improve equity of Mass Administration of Medicines (MAM) and inform Neglected Tropical Disease (NTD) policy through an enhanced community engagement strategy. A situational analysis conducted i...
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities throughout the Organization and encouraging participation in the WHO Programme for International Drug...
The WHO South-East Asia (SEA) Region bears a high burden of tuberculosis (TB) and MDR-TB. In 2015, the Region accounted for nearly 200 000 or 35% of the global estimated new RR/MDR-TB cases eligible for treatment. Extensively drug-resistant TB (XDRTB) has also been reported from s...
2018
9th Edition
Offering information on HIV/AIDS treatment, prevention, and research
Antimicrobial resistance represents a big threat to public health. The Centers for Disease Control and Prevention (CDC) estimate that every year two million Americans are infected with a (multi-)drug resistant bacterium, resulting in 23,000 deaths. The WHO has repeatedly drawn attention to this majo...
Overuse and misuse of antibiotics in animals and humans is contributing to the rising threat of antibiotic resistance. Some types of bacteria that cause serious infections in humans have already developed resistance to most or all of the available treatments, and there are very...
The conduct of COVID-19 vaccine trials in the context of a candidate vaccine being issued with Emergency Use Designation raises challenging ethical questions, including in relation to the use of placebo controls and unblinding of trial participants in current and future COVID-19 vaccine trials. This...
The Infection Prevention and Control (IPC) Legal Framework comes before the Specialized Technical Committee on Health and Drug Control for adoption and endorsement. The IPC Legal Framework is designed to guide Member States in the review and strengthening of laws and policies that support IPC at bot...
In response to the recent publication “Is onchocerciasis elimination in Africa feasible by 2025: a perspective based on lessons learnt from the African control programmes” by Dadzie et al., it is important to clarify and highlight the positive and unequivocal research and operational contributio...
